NPM1 and acute myeloid leukemia: However, when analyzing molecular subtypes within the AML study cohort, several AML-subtypes show worse prognosis with high MEN1 expression, including NPM1-mutated, which has been shown to be sensitive to MEN1 inhibition [22,23] (Supplementary Figure S1A).